Pharmacology, Toxicology and Pharmaceutical Science
Mycobacterium Tuberculosis
100%
Drug Resistance
100%
Dihydrofolate Reductase
100%
Thymidylate Synthase
100%
Isoniazid
81%
Aminosalicylic Acid
63%
Cotrimoxazole
63%
Reduced Nicotinamide Adenine Dinucleotide Phosphate
36%
Acid
27%
Mycobacterium Bovis BCG
27%
Cross-Resistance
18%
Ethionamide
18%
4,6 Diamino 1,2 Dihydro 2,2 Dimethyl 1 [3 (2,4,5 Trichlorophenoxy)propoxy] 1,3,5 Triazine
18%
Staphylococcus Aureus
9%
Dihydrofolate Reductase Inhibitor
9%
Osteophyte
9%
Antimalarial Agent
9%
Antibiotic Agent
9%
Amino Acid
9%
Antibiotic Resistance
9%
Escherichia coli
9%
Dihydropteroate Synthase
9%
Tetrahydrofolic Acid
9%
Methylenetetrahydrofolic Acid
9%
Deoxyuridine Phosphate
9%
Methotrexate
9%
Biochemistry, Genetics and Molecular Biology
Dihydrofolate Reductase
100%
Thymidylate Synthase
100%
Mycobacterium Tuberculosis
100%
Drug Resistance
100%
Trimethoprim
63%
Sulfamethoxazole
63%
Wild Type
45%
Mycobacterium Bovis BCG
27%
Transposable Element
18%
Cross Resistance
18%
Methylation
9%
Crystal Structure
9%
Protein Sequencing
9%
Antibiotic Resistance
9%
Methotrexate
9%
Dihydropteroate Synthase
9%
Tetrahydrofolate
9%
Dihydrofolate Reductase Inhibitor
9%
Escherichia coli
9%
Staphylococcus Aureus
9%
Competitive Inhibition
9%
Amino Acid Substitution
9%
Immunology and Microbiology
Drug Resistance
100%
Wild Type
100%
Mycobacterium Tuberculosis
100%
Mycobacterium Bovis BCG
60%
Cross-Resistance
40%
Transposon
40%
Antimicrobial Resistance
20%
Competitive Inhibition
20%
Methotrexate
20%
Escherichia coli
20%
Crystal Structure
20%
Methylation
20%
Staphylococcus Aureus
20%
Sequence Analysis
20%
Antimalarial Agent
20%
Amino Acid Substitution
20%
Neuroscience
Drug Resistance
100%
Dihydrofolate Reductase
100%
Thymidylate Synthase
100%
Trimethoprim/Sulfamethoxazole
63%
4-Aminosalicylic Acid
63%
Reduced Nicotinamide Adenine Dinucleotide Phosphate
36%
Isoniazid
18%
Ethionamide
18%
Transposon
18%
Methylation
9%
Antibiotic Resistance
9%
Tetrahydrofolic Acid
9%
Combination Drug
9%
Deoxyuridine Monophosphate
9%
In Vitro
9%
Competitive Inhibition
9%
Amino Acid Substitution
9%
Methotrexate
9%
Antimalarial Agent
9%
Dihydrofolate Reductase Inhibitor
9%
Methylenetetrahydrofolic Acid
9%
Dihydropteroate Synthase
9%
Keyphrases
Tuberculosis Drug Resistance
100%
Methylenetetrahydrofolate Reductase (MTHFR)
100%
Thymidylate Synthase
100%
Trimethoprim-sulfamethoxazole (TMP-SMX)
46%
INH Resistance
30%
Resistance Mechanisms
23%
Cross-resistance
15%
M. Bovis BCG
15%
Ethionamide
15%
Trimethoprim-sulfamethoxazole Resistance
7%
Hypermutability
7%
Personal Communication
7%
Competitive Inhibition
7%
Antimalarial Drugs
7%
Small Colony Variants
7%
BCG Strain
7%
Methylation Modification
7%
Dihydrofolate Reductase Inhibitors
7%
Tetrahydrofolate
7%
Drug Combination
7%
Mycobacterium Bovis BCG
7%
Treatment History
7%
Dihydropteroate Synthase
7%
Phenotypic Drug Susceptibility Testing
7%
Long-term Persistence
7%
Methotrexate
7%
5-methyltetrahydrofolate
7%
Inhibitor Binding
7%
Spur
7%
Amino Acid Substitution
7%
Clinical Impact
7%